Linsen Ye
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction.
Journal: Journal of hepatology
Published: February 09, 2026
Hepatic Stellate Cell-Specific METTL3 Deficiency Promotes Hepatocellular Carcinoma Progression via BMP10-SMAD1/5/8 Signaling.
Journal: Cancer research communications
Published: December 04, 2025
Low-dose chemotherapy remodels hepatic immune landscape and potentiates anti-tumor response to immune checkpoint blockade in cholangiocarcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: November 01, 2025
The dual roles of natural killer cells in liver immunity and tolerance: Implications for health and disease.
Journal: Hepatology communications
Published: September 27, 2025
Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: July 18, 2025
Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma.
Journal: Biomaterials
Published: June 01, 2025
N6-methyladenosine-mediated up-regulation of ARRB2 regulates intrahepatic cholangiocarcinoma malignant progression and pemigatinib resistance through MAPK and Hippo signaling pathways.
Journal: Cell death & disease
Published: April 30, 2025
Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion.
Journal: Chinese medical journal
Published: December 26, 2024
FXR inhibition functions as a checkpoint blockade of the pathogenic Tfh cell response in lupus.
Journal: Cellular & molecular immunology
Published: December 11, 2024
Lactate accumulation drives hepatocellular carcinoma metastasis through facilitating tumor-derived exosome biogenesis by Rab7A lactylation.
Journal: Cancer letters
Published: November 04, 2024
METTL3 knockout accelerates hepatocarcinogenesis via inhibiting endoplasmic reticulum stress response.
Journal: FEBS open bio
Published: September 21, 2024
Dynamic network biomarker C1QTNF1 regulates tumor formation at the tipping point of hepatocellular carcinoma.
Journal: Biomolecules & biomedicine
Published: November 28, 2023
Last Updated: 09/26/2026